SEMA4D and atypical Rett syndrome: Therefore, anti-SEMA4D therapy remains a potential treatment for individuals diagnosed with Rett syndrome until such time that early intervention strategies such as pre-natal testing or early genetic testing are implemented in healthcare systems.